Editas Medicine Inc (EDIT)
2.95
+0.04
(+1.37%)
USD |
NASDAQ |
Nov 04, 13:02
Editas Medicine 1 Year Total Returns (Daily): -57.83% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | -57.83% |
October 31, 2024 | -56.59% |
October 30, 2024 | -52.29% |
October 29, 2024 | -50.32% |
October 28, 2024 | -47.92% |
October 25, 2024 | -51.96% |
October 24, 2024 | -51.60% |
October 23, 2024 | -48.64% |
October 22, 2024 | -47.69% |
October 21, 2024 | -40.22% |
October 18, 2024 | -49.09% |
October 17, 2024 | -51.40% |
October 16, 2024 | -52.48% |
October 15, 2024 | -52.34% |
October 14, 2024 | -54.04% |
October 11, 2024 | -55.57% |
October 10, 2024 | -59.17% |
October 09, 2024 | -55.49% |
October 08, 2024 | -55.66% |
October 07, 2024 | -55.10% |
October 04, 2024 | -52.06% |
October 03, 2024 | -56.34% |
October 02, 2024 | -54.90% |
October 01, 2024 | -58.08% |
September 30, 2024 | -56.28% |
Date | Value |
---|---|
September 27, 2024 | -51.05% |
September 26, 2024 | -50.53% |
September 25, 2024 | -52.29% |
September 24, 2024 | -55.03% |
September 23, 2024 | -53.38% |
September 20, 2024 | -52.58% |
September 19, 2024 | -51.06% |
September 18, 2024 | -51.56% |
September 17, 2024 | -53.99% |
September 16, 2024 | -54.35% |
September 13, 2024 | -53.36% |
September 12, 2024 | -58.33% |
September 11, 2024 | -58.78% |
September 10, 2024 | -58.20% |
September 09, 2024 | -61.09% |
September 06, 2024 | -60.64% |
September 05, 2024 | -60.48% |
September 04, 2024 | -61.45% |
September 03, 2024 | -61.56% |
August 30, 2024 | -58.63% |
August 29, 2024 | -59.05% |
August 28, 2024 | -59.20% |
August 27, 2024 | -56.44% |
August 26, 2024 | -55.30% |
August 23, 2024 | -55.77% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-79.67%
Minimum
Sep 02 2022
206.9%
Maximum
Mar 16 2021
-8.40%
Average
-21.75%
Median
1 Year Total Returns (Daily) Benchmarks
EyePoint Pharmaceuticals Inc | 66.57% |
Cassava Sciences Inc | 21.62% |
Regeneron Pharmaceuticals Inc | 6.61% |
Vertex Pharmaceuticals Inc | 27.56% |
Adverum Biotechnologies Inc | -18.80% |